Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatments for Fathers With Attention Deficit/Hyperactivity Disorder (ADHD) and Their At-Risk Children (Fathers Too)

NCT02675400 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT02675400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02675400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatments for Fathers With Attention Deficit/Hyperactivity Disorder (ADHD) and Their At-Risk Children (Fathers Too)
Lead sponsor
Seattle Children's Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2015
Completion date
August 31, 2018
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit/hyperactivity disorder (adhd)